We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIO icon
3026
Helios Technologies
HLIO
$2.76B
$1.87K ﹤0.01%
+56
New +$1.69K
PTCT icon
3027
PTC Therapeutics
PTCT
$6.12B
$1.86K ﹤0.01%
38
SDGR icon
3028
Schrodinger
SDGR
$1.36B
$1.85K ﹤0.01%
92
-19
-17% -$434
OLPX
3029
DELISTED
Olaplex Holdings
OLPX
$1.85K ﹤0.01%
1,320
-4,981
-79% -$6.49K
RMR icon
3030
The RMR Group
RMR
$332M
$1.85K ﹤0.01%
113
CLOU icon
3031
Global X Cloud Computing ETF
CLOU
$263M
$1.84K ﹤0.01%
79
GRFS
3032
Grifois
GRFS
$5.4B
$1.83K ﹤0.01%
202
-815
-80% -$6.37K
WULF icon
3033
TeraWulf
WULF
$8.52B
$1.82K ﹤0.01%
416
+331
+389% +$1.13K
CONY icon
3034
YieldMax COIN Option Income Strategy ETF
CONY
$336M
$1.8K ﹤0.01%
20
+10
+100% +$803
SEZL
3035
Sezzle
SEZL
$3.97B
$1.79K ﹤0.01%
10
-6
-38% -$531
AVBP icon
3036
ArriVent BioPharma
AVBP
$1.44B
$1.78K ﹤0.01%
+82
New +$1.7K
PHAT icon
3037
Phathom Pharmaceuticals
PHAT
$692M
$1.78K ﹤0.01%
186
-143
-43% -$791
BRKL
3038
DELISTED
Brookline Bancorp
BRKL
$1.78K ﹤0.01%
169
RVMD icon
3039
Revolution Medicines
RVMD
$44B
$1.77K ﹤0.01%
48
-463
-91% -$17.8K
TIGO icon
3040
Millicom
TIGO
$16.3B
$1.76K ﹤0.01%
47
SKY icon
3041
Champion Homes
SKY
$5.14B
$1.75K ﹤0.01%
28
-9
-24% -$700
SCHR
3042
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$1.75K ﹤0.01%
70
-300
-81% -$7.43K
AVO icon
3043
Mission Produce
AVO
$1.17B
$1.74K ﹤0.01%
148
-355
-71% -$3.85K
LCII icon
3044
LCI Industries
LCII
$2.65B
$1.73K ﹤0.01%
19
-9
-32% -$767
ADEA icon
3045
Adeia
ADEA
$3.11B
$1.73K ﹤0.01%
122
ARTNA icon
3046
Artesian Resources
ARTNA
$358M
$1.71K ﹤0.01%
+51
New +$1.73K
TBLA icon
3047
Taboola.com
TBLA
$1.11B
$1.7K ﹤0.01%
463
-753
-62% -$2.46K
MSGE icon
3048
Madison Square Garden
MSGE
$3.62B
$1.68K ﹤0.01%
42
+11
+35% +$389
BZ icon
3049
Kanzhun
BZ
$7.36B
$1.68K ﹤0.01%
94
-54
-36% -$907
JBLU icon
3050
JetBlue
JBLU
$2.29B
$1.67K ﹤0.01%
395
-1,568
-80% -$7.02K

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.